Bohui Innovation Biotechnology Secures Approval for Virus Detection Kit
Beijing Bohui Innovation Biotechnology received regulatory approval from China's medical products administrator for a third class in vitro diagnostic reagent. The nucleic acid detection kit targets rotavirus, norovirus, enteric adenovirus, astrovirus and sapovirus in stool samples, according to a May 31 filing with the Shenzhen bourse. The certificate is valid until May 28, 2030.
Beijing Bohui Innovation Biotechnology received regulatory approval from China's medical products administrator for a third class in vitro diagnostic reagent.
The nucleic acid detection kit targets rotavirus, norovirus, enteric adenovirus, astrovirus and sapovirus in stool samples, according to a May 31 filing with the Shenzhen bourse.
The certificate is valid until May 28, 2030.
